×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

SMART approach lowers risk of asthma exacerbations

  1870 Views

eMediNexus    22 March 2018

Adopting the SMART (single maintenance and reliever therapy) treatment approach of using an inhaled corticosteroid (ICS) and the long-acting β2-agonist formoterol significantly lowers the risk of asthma exacerbations, according to a systematic review and meta-analysis reported in JAMA.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.